- Report
- March 2025
- 513 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2024
Global
From €7120EUR$7,500USD£6,006GBP
- Report
- October 2023
- 102 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- June 2022
- 125 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- October 2023
- 146 Pages
Global
From €3349EUR$3,528USD£2,825GBP
€3940EUR$4,150USD£3,323GBP
- Report
- October 2023
- 85 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- September 2023
- 96 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- March 2024
- 132 Pages
Global
From €902EUR$950USD£761GBP
Ultrasound contrast agents are a type of contrast media used to enhance the visibility of organs and tissues during ultrasound imaging. These agents are composed of tiny gas-filled microbubbles that are injected into the bloodstream and can be detected by ultrasound. Ultrasound contrast agents are used to improve the accuracy of ultrasound imaging, allowing for better diagnosis and treatment of various medical conditions. They are also used to detect and monitor blood flow, and to detect and measure the size of tumors.
Ultrasound contrast agents are used in a variety of medical applications, including cardiology, obstetrics, and oncology. They are also used in research and development of new medical treatments. The use of ultrasound contrast agents is increasing due to their safety and effectiveness.
Some companies in the ultrasound contrast agent market include Bracco Diagnostics, Lantheus Medical Imaging, Guerbet, and GE Healthcare. Show Less Read more